Stericon Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.75 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.37 Cr
as on 16-11-2024
- Company Age 34 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 16.96 Cr
as on 16-11-2024
- Revenue 21.42%
(FY 2023)
- Profit 14.39%
(FY 2023)
- Ebitda 18.48%
(FY 2023)
- Net Worth 16.52%
(FY 2023)
- Total Assets 12.18%
(FY 2023)
About Stericon Pharma
The Corporate was formerly known as Vista Optics (I) Pvt Ltd. The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.75 Cr and a paid-up capital of Rs 4.37 Cr.
The company has closed loans amounting to ₹16.96 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Amar Shah, Ajay Khushu, and Chinmay Vasa serve as directors at the Company.
- CIN/LLPIN
U33201KA1990PTC011056
- Company No.
011056
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 1990
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Stericon Pharma Private Limited offer?
Stericon Pharma Private Limited offers a wide range of products and services, including Disposable & Other Optical Lenses, Lenses, Contact Lenses, Soft Contact Lenses, Contact Lens Accessories, Contact Lens Cleaners.
Who are the key members and board of directors at Stericon Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amar Shah  | Director | 29-Mar-2023 | Current |
| Ajay Khushu | Additional Director | 10-Apr-2024 | Current |
| Chinmay Vasa | Director | 29-Mar-2023 | Current |
Financial Performance and Corporate Structure Insights of Stericon Pharma.
Stericon Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.42% increase. The company also saw a substantial improvement in profitability, with a 14.39% increase in profit. The company's net worth Soared by an impressive increase of 16.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stericon Pharma?
In 2023, Stericon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aculife Healthcare Private LimitedActive 10 years 4 monthsAmar Shah and Ajay Khushu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Mar 2020 | ₹10.00 Cr | Satisfied |
Others Creation Date: 16 Dec 2016 | ₹4.60 M | Satisfied |
Hdfc Bank Limited Creation Date: 03 Oct 2016 | ₹4.90 M | Satisfied |
How Many Employees Work at Stericon Pharma?
Stericon Pharma has a workforce of 176 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stericon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stericon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
